• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these drugs may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who take get adhd medication online medications must weigh the benefits of taking them against potential risks to the foetus. The doctors don't have the information to provide clear recommendations, but can provide information on risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face an increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a large population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure accurate classification of the cases and to reduce the chance of bias.

However, the researchers' study was not without its flaws. The most important issue was that they were not able to differentiate the effects of the medication from the underlying disorder. This makes it difficult for researchers to determine whether the small differences observed between the groups that were exposed to medication use or confounded by co-morbidities. The researchers did not examine long-term outcomes for the offspring.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The researchers suggest that the small risk associated with the use of adhd medication in uk medications during early pregnancy could be offset by the greater benefit to both mother and child of continued treatment best medicine for adhd and social anxiety the woman's condition. Physicians should talk to their patients about this and, if possible, help them develop coping strategies that can lessen the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the question of whether to keep or end treatment during pregnancy is a question that doctors are having to confront. These decisions are often made without clear and reliable evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other physicians and the research that has been conducted on the subject.

The issue of risk to infants is extremely difficult. The research on this subject is based on observations rather than controlled studies, and a lot of the results are in conflict. The majority of studies focus on live births, which may underestimate the severity of teratogenic effects which can cause terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion A few studies have revealed an association between ADHD medications and certain birth defects, other studies have not found a correlation. Most studies show that there is a neutral, or slight negative impact. As a result an accurate risk-benefit analysis must be conducted in every instance.

For women suffering from ADHD and ADD, the decision to discontinue medication is difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication for adults uk medications during pregnancy can cause depression and feelings of being isolated. Additionally, the loss of medication may affect the ability to complete jobs and drive safely that are crucial aspects of a normal life for a lot of people with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or discontinue it due to pregnancy educate family members, coworkers and acquaintances about the condition, the effects on daily functioning, and the benefits of keeping the current treatment regimen. It can also help the woman feel supported in her struggle with her decision. Certain medications can pass through the placenta. If the patient decides to not take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the medication may be transferred to her infant.

Birth Defects and Risk of

As the use and use of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases as does the concern about the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Researchers used two huge data sets to examine more than 4.3 million pregnancies and determine if the use of stimulant medications caused birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.

The researchers behind the study found no link between early use of medication and congenital abnormalities like facial clefting, or club foot. The results are in the same vein as previous studies that showed a small, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of the birth of their child. The risk increased in the latter part of pregnancy when many women began to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby that required breathing assistance during birth. The researchers of the study could not eliminate selection bias because they limited the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they encounter pregnant women. The researchers recommend that while discussing benefits and risks are crucial, the decision about whether to continue or stop taking medication should be in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors warn that, even though stopping the medication is an option to consider, it is not recommended due to the high prevalence of depression and mental health issues among women who are pregnant or have recently given birth. Additionally, research suggests that women who stop taking their medications will have a harder time adjusting to a life without them once the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments as well as getting ready for the arrival of a baby and adjusting to new household routines can experience severe challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications pass through breast milk in low amounts, therefore the risk to nursing infant is very low. However, the rate of medication exposure to the newborn may differ based on dosage, frequency it is administered and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract, or through breast milk. The impact of these medications on a newborn's health is not fully understood.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the potential risks to the foetus. In the meantime, until more information is available, GPs may ask pregnant patients whether they have a background of ADHD or if they plan to take medication in the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication without risk during pregnancy and breast-feeding. This has led to more and more patients are choosing to do so and, in consultation with their physician, they have discovered that the benefits of keeping their current medication outweigh any risks.

Women who suffer from ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with inattentive adhd medication recognize the signs and underlying disorder. They should also be informed about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counselling should include the discussion of a plan for management for both mother and child, and monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.